![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Departments of Pharmacy (W.Z.) and Biochemistry (T.M.C.T.), National University of Singapore, Singapore; and Department of Pharmacy, School of Biomedical, Biomolecular and Chemical Sciences, University of Western Australia, Crawley, Western Australia, Australia (L.-Y.L.)
The aim of this study was to evaluate whether curcumin could modulate P-glycoprotein (P-gp) and CYP3A expression, and in turn modify the pharmacokinetic profiles of P-gp and CYP3A substrates in male Sprague-Dawley rats. Intragastric gavage of the rats with 60 mg/kg curcumin for 4 consecutive days led to a down-regulation of the intestinal P-gp level. There was a concomitant upregulation of hepatic P-gp level, but the renal P-gp level was unaffected. Curcumin also attenuated the CYP3A level in the small intestine but induced CYP3A expression in the liver and kidney. Regular curcumin consumption also caused the Cmax and area under the concentration-time curve (AUC08 and total AUC) of peroral celiprolol (a P-gp substrate with negligible cytochrome P450 metabolism) at 30 mg/kg to increase, but the apparent oral clearance (CLoral) of the drug was reduced. Similarly, rats treated with curcumin for 4 consecutive days showed higher AUC (AUC04 and total AUC) and lower CLoral for peroral midazolam (a CYP3A substrate that does not interact with the P-gp) at 20 mg/kg in comparison with vehicle-treated rats. In contrast, curcumin administered 30 min before the respective drug treatments did not significantly modify the pharmacokinetic parameters of the drugs. Analysis of the data suggests that the changes in the pharmacokinetic profiles of peroral celiprolol and midazolam in the rat model were contributed mainly by the curcumin-mediated down-regulation of intestinal P-gp and CYP3A protein levels, respectively.
This article has been cited by other articles:
![]() |
L. P. Volak, S. Ghirmai, J. R. Cashman, and M. H. Court Curcuminoids Inhibit Multiple Human Cytochromes P450, UDP-Glucuronosyltransferase, and Sulfotransferase Enzymes, whereas Piperine Is a Relatively Selective CYP3A4 Inhibitor Drug Metab. Dispos., August 1, 2008; 36(8): 1594 - 1605. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang and L.-Y. Lim Effects of Spice Constituents on P-Glycoprotein-Mediated Transport and CYP3A4-Mediated Metabolism in Vitro Drug Metab. Dispos., July 1, 2008; 36(7): 1283 - 1290. [Abstract] [Full Text] [PDF] |
||||